The story of Viagra, formerly marketed by copyright, presents a complex case study for investors considering the drug sector. Despite its initial success and generation of billions in revenue , the https://ztndz.com/story28870078/copyright-s-drug-and-a-pharmaceutical-sector-a-risky-investment